Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP807622.RAqWzn_gxbeC0p4C2BRVTPKO3OrJMNw9Tk_qbTa7TrPLM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP807622.RAqWzn_gxbeC0p4C2BRVTPKO3OrJMNw9Tk_qbTa7TrPLM130_assertion type Assertion NP807622.RAqWzn_gxbeC0p4C2BRVTPKO3OrJMNw9Tk_qbTa7TrPLM130_head.
- NP807622.RAqWzn_gxbeC0p4C2BRVTPKO3OrJMNw9Tk_qbTa7TrPLM130_assertion description "[We evaluated whether the expression of PrPc was associated with the resistance to adjuvant chemotherapy in patients with estrogen receptor (ER) -negative breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP807622.RAqWzn_gxbeC0p4C2BRVTPKO3OrJMNw9Tk_qbTa7TrPLM130_provenance.
- NP807622.RAqWzn_gxbeC0p4C2BRVTPKO3OrJMNw9Tk_qbTa7TrPLM130_assertion evidence source_evidence_literature NP807622.RAqWzn_gxbeC0p4C2BRVTPKO3OrJMNw9Tk_qbTa7TrPLM130_provenance.
- NP807622.RAqWzn_gxbeC0p4C2BRVTPKO3OrJMNw9Tk_qbTa7TrPLM130_assertion SIO_000772 17872899 NP807622.RAqWzn_gxbeC0p4C2BRVTPKO3OrJMNw9Tk_qbTa7TrPLM130_provenance.
- NP807622.RAqWzn_gxbeC0p4C2BRVTPKO3OrJMNw9Tk_qbTa7TrPLM130_assertion wasDerivedFrom befree-20140225 NP807622.RAqWzn_gxbeC0p4C2BRVTPKO3OrJMNw9Tk_qbTa7TrPLM130_provenance.
- NP807622.RAqWzn_gxbeC0p4C2BRVTPKO3OrJMNw9Tk_qbTa7TrPLM130_assertion wasGeneratedBy ECO_0000203 NP807622.RAqWzn_gxbeC0p4C2BRVTPKO3OrJMNw9Tk_qbTa7TrPLM130_provenance.